Baseline expression of immune gene modules in blood is associated with primary response to anti-TNF therapy in Crohn's disease patients.

Baseline gene module expression was associated with primary response to anti-TNF therapy in PANTS patients. However, these baseline expression differences did not predict response with sufficient sensitivity for clinical use.